37 Supported by research
Lactate produced during exercise is used by the heart and brain as a preferred source of energy.
"and that is that it is something that is produced during exercise and it's used by, you know, the heart and the brain as a preferred source of energy." (said at 0:00:30)
Extensive physiological and tracer studies support that lactate produced during exercise serves as a major and preferred oxidative fuel source for both the myocardium (heart) and the brain. Through the cell-cell lactate shuttle, circulating lactate taken up by cardiac myocytes and cerebral neurons/astrocytes is readily oxidized for ATP production, sparing or displacing other substrates such as glucose during periods of elevated blood lactate.
- supports: Lactate as a myokine and exerkine: drivers and signals of physiology and metabolism. (Journal of applied physiology (Bethesda, Md. : 1985) 2023) · cited 154x in the literature
"For instance, lactate signaling is: involved in reproductive biology, fueling the heart, muscle adaptation, and brain executive function, growth and development, and a treatment for inflammatory conditions." (abstract, passage verified)
pubmedfull study (doi) - supports: Muscle Fuel Utilization with Glycolysis Viewed Right Side Up. (Advances in experimental medicine and biology 2025) · cited 1x in the literature
"From contemporary studies of muscle and other tissues and whole-body metabolism, we now know that lactate is continuously produced under fully aerobic conditions in a variety of cells, tissues, and organs and serves at least three purposes-lactate is a preferred energy substrate, the major gluconeogenic precursor, and a signaling molecule." (abstract, passage verified)
pubmedfull study (doi)
Glycolysis and lactate production occur continuously in all cells, where lactate acts as a fuel, a precursor for blood glucose, and a signaling molecule.
"glycolysis—the breakdown of sugar and glycogen—happens all the time in all cells, and we use it. We use it as a fuel. We use it to support our blood sugar level. We use it as a signaling molecule to activate certain metabolic processes. It's made in some cells, and it's used in other cells." (said at 0:03:05)
Extensive metabolic physiology research confirms the speaker's statement. Rather than being merely an anaerobic waste product, lactate is continuously produced under fully aerobic conditions and shuttles between producer (source) and consumer (sink) cells. Across human and mammalian studies, lactate is established as fulfilling three major metabolic roles: serving as a major oxidative fuel for tissues such as the heart, brain, and skeletal muscle; acting as the primary gluconeogenic precursor in the liver and kidneys to maintain blood glucose levels; and functioning as an autocrine, paracrine, and endocrine signaling molecule.
- supports: The Science and Translation of Lactate Shuttle Theory. (Cell metabolism 2018) · cited 1444x in the literature
"Once thought to be a waste product of anaerobic metabolism, lactate is now known to form continuously under aerobic conditions. Shuttling between producer and consumer cells fulfills at least three purposes for lactate: (1) a major energy source, (2) the major gluconeogenic precursor, and (3) a signaling molecule." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Muscle Fuel Utilization with Glycolysis Viewed Right Side Up. (Advances in experimental medicine and biology 2025) · cited 1x in the literature
"From contemporary studies of muscle and other tissues and whole-body metabolism, we now know that lactate is continuously produced under fully aerobic conditions in a variety of cells, tissues, and organs and serves at least three purposes-lactate is a preferred energy substrate, the major gluconeogenic precursor, and a signaling molecule." (abstract, results, passage verified)
pubmedfull study (doi)
Lactate transporters are located in plasma membranes and within the mitochondrial reticulum as lactate/pyruvate transporters.
"our unique contribution was to find that not only are they in the plasma membranes of muscles and heart and other tissues, but they're also in the mitochondria. They are the lactate/pyruvate transporter." (said at 0:06:37)
Published cell biology and biochemical studies confirm that monocarboxylate/lactate transporters (such as MCT1) are located both in plasma/sarcolemmal membranes and within the mitochondrial reticulum/inner mitochondrial membrane of cardiac muscle, skeletal muscle, and other tissues, where they transport monocarboxylates like lactate and pyruvate into mitochondria for oxidation.
- supports: Cardiac and skeletal muscle mitochondria have a monocarboxylate transporter MCT1. (Journal of applied physiology (Bethesda, Md. : 1985) 1999) · cited 183x in the literature
"Western blots indicated presence of MCT1 in sarcolemmal membranes and in subsarcolemmal and interfibrillar mitochondria." (abstract, results, passage verified)
pubmedfull study (doi) - supports: MCT1 confirmed in rat striated muscle mitochondria. (Journal of applied physiology (Bethesda, Md. : 1985) 2004) · cited 84x in the literature
"MCT1 was found in the mitochondria, as well as in the sarcolemmal membrane and whole muscle homogenates." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Colocalization of MCT1, CD147, and LDH in mitochondrial inner membrane of L6 muscle cells:… (American journal of physiology. Endocrinology and metabolism 2006) · cited 249x in the literature
"CLSM showed that LDH, MCT1, and CD147 are colocalized with the mitochondrial reticulum." (abstract, results, passage verified)
pubmedfull study (doi)
Endurance training leads to lower blood lactate at any given power output because trained individuals have superior lactate clearance and utilization.
"So one of the things we found is that the classic training response that people have is to have a lower lactate at any power output. So if I would compare myself to a young, healthy athlete, that athlete would actually be producing more lactate than I would be, but my lactate level would be really high because I'm limited in my ability to take it up and use it, whereas the athlete is superior in terms of clearing lactate and using it as a fuel and using it as a gluconeogenic precursor." (said at 0:08:09)
Human and animal metabolic tracer studies confirm that endurance training results in lower arterial blood lactate concentrations at given absolute and relative power outputs. This adaptation is largely driven by enhanced metabolic clearance rate (uptake, oxidation as fuel, and gluconeogenic precursor utilization) in active skeletal muscle and other tissues, in addition to reduced net lactate release at submaximal workloads.
Trained athletes produce more lactate than untrained individuals, but clear and remove it more rapidly.
"And athletes actually produce more than people who are less capable or less highly trained, but they remove it; they use it." (said at 0:08:41)
Tracer kinetic studies in humans demonstrate that trained endurance athletes have higher capacities for both lactate production (rate of appearance) and lactate clearance/oxidation (rate of disposal and metabolic clearance rate) compared to untrained individuals. While lactate production is lower in trained individuals at the same absolute submaximal workload due to enhanced mitochondrial oxidative efficiency, at maximal workloads and at the lactate threshold, athletes achieve higher absolute rates of lactate production and simultaneously clear and utilize lactate much more rapidly.
- supports: Active muscle and whole body lactate kinetics after endurance training in men. (Journal of applied physiology (Bethesda, Md. : 1985) 1999) · cited 274x in the literature
"We conclude that 1) active skeletal muscle is not solely responsible for elevated [lactate](a); and 2) training increases leg lactate clearance, decreases whole body and leg lactate production at a given moderate-intensity power output, and increases both whole body and leg lactate clearance at a high relative power output." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Lactate kinetics at the lactate threshold in trained and untrained men. (Journal of applied physiology (Bethesda, Md. : 1985) 2013) · cited 161x in the literature
"At LT, lactate Ra was higher in T (24.1 ± 2.7) than in UT (14.6 ± 2.4; P < 0.05)... At LT, MCR in T (62.5 ± 5.0) subjects was 34% higher than in UT (46.5 ± 7.0; P < 0.05)... We conclude that 1) lactate MCR reaches an apex below the LT, 2) LT corresponds to a limitation in MCR, and 3) endurance training augments capacities for lactate production, disposal and clearance." (abstract, results and conclusions)
pubmedfull study (doi)
Physical exercise training can double the amount of mitochondrial mass in human muscle.
"So you can actually double the amount of mitochondria you have in your muscle by training. That's really one of the most incredible adaptations we know about." (said at 0:09:13)
Substantial evidence in exercise physiology demonstrates the remarkable plasticity of skeletal muscle mitochondrial content in response to exercise training. While typical short- to moderate-term training interventions in previously untrained adults commonly produce a 30% to 50% increase in mitochondrial content and volume density, prolonged or high-volume endurance training can result in up to a two-fold (100%) difference compared to sedentary baseline levels, as observed in longitudinal training adaptations and cross-sectional comparisons between trained athletes and sedentary controls.
- supports: Can we optimise the exercise training prescription to maximise improvements in mitochondri… (Biochimica et biophysica acta 2014) · cited 189x in the literature
"While there is agreement that exercise is a powerful stimulus to increase both mitochondrial function and content, we do not know the optimal training stimulus to maximise improvements in mitochondrial biogenesis... In contrast, it appears that training volume, rather than training intensity, may be an important determinant of exercise-induced improvements in mitochondrial content. Exercise-induced mitochondrial adaptations are quickly reversed following a reduction or cessation of physical activity, highlighting that skeletal muscle is a remarkably plastic tissue." (abstract, conclusions, passage verified)
pubmedfull study (doi)
Exercise training can double the quantity of lactate transporters in skeletal muscle.
"And as well, you can double the amount of lactate transporters." (said at 0:09:13)
Endurance and high-intensity interval training significantly upregulate the expression and protein content of monocarboxylate transporters (primarily MCT1 and MCT4) in skeletal muscle. Clinical training studies have demonstrated increases of up to ~90% (near doubling) in total muscle MCT1 content after endurance training programs, alongside increases in mitochondrial and sarcolemmal transporter abundance.
- supports: Endurance training, expression, and physiology of LDH, MCT1, and MCT4 in human skeletal mu… (American journal of physiology. Endocrinology and metabolism 2000) · cited 384x in the literature
"MCT1 amounts significantly increased in MU, SL, and MI after training (+90%, +60%, and +78%, respectively), whereas SL but not MU MCT4 content increased after training (+47%, P < 0.05)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Exercise influence on monocarboxylate transporter 1 (MCT1) and 4 (MCT4) in the skeletal mu… (Acta physiologica (Oxford, England) 2024) · cited 20x in the literature
"The main findings indicate that exercise is a powerful stimulus to increase MCT1 protein content in human muscle. MCT4 protein level increases can also be observed after a training program, although its responsiveness is lower compared to MCT1." (abstract, results, passage verified)
pubmedfull study (doi)
Incubating muscle cells with lactate upregulates over 600 genes associated with muscle adaptation and mitochondrial biogenesis.
"But we know from our studies that we've done with incubated muscle cells that if we just take muscle cells and we incubate them with lactate, we'll upregulate over 600 genes, all the genes basically of muscle adaptation." (said at 0:11:46)
In vitro experimental work demonstrates that incubating muscle cells with lactate stimulates cell signaling cascades and activates a broad transcriptional network, inducing the expression of monocarboxylate transporters (such as MCT1), mitochondrial components, and genes regulating mitochondrial biogenesis and metabolic adaptation. Because this evidence is derived entirely from isolated cell culture models rather than in vivo human physiological trials, the overall certainty is graded as very low.
Glycolysis produces lactate rather than lactic acid, and exercise acidosis is caused by protons liberated from ATP hydrolysis.
"Well, if you look at the glycolytic pathway, it actually makes lactate. But lactate is a pretty strong acid, so it associates with water, and a certain amount of acidosis that will be associated with the lactate itself. But glycolysis actually makes lactate, not lactic acid. The acidosis, the hydrogen ions, come from other processes like the splitting of ATP, which is our high-energy source. When we split that, we liberate a proton." (said at 0:16:50)
The speaker's main biochemical assertion—that glycolysis produces lactate rather than lactic acid and that exercise-induced acidosis is driven by protons released from non-mitochondrial ATP hydrolysis—is supported by published biochemical analyses of metabolic pathways during high-intensity exercise. In cellular conditions, the lactate dehydrogenase reaction converts pyruvate to lactate while consuming protons (acting as a metabolic buffer rather than an acid producer). Proton accumulation during intense muscle work primarily originates from the hydrolysis of ATP to ADP and inorganic phosphate when ATP regeneration demands exceed mitochondrial oxidative phosphorylation capacity.
Lactic acid has a pKa of approximately 3, meaning it is completely dissociated into lactate anion and a proton at physiological pH.
"Well, the pKa is really is about 3. So if there was lactic acid, it would be completely dissociated to its lactate anion and a proton." (said at 0:17:51)
Lactic acid is a weak organic acid with an acid dissociation constant (pKa) of approximately 3.86. Because physiological pH (typically ~7.0 to 7.4 in human tissues and blood) is more than three pH units above this pKa, lactic acid is almost entirely dissociated (>99.9%) into its conjugate base, the lactate anion, and a proton (H+).
Ingesting polyLactate during exercise slightly elevates blood pH by binding endogenous protons.
"And so when we take our polyLactate and people consume it while they're exercising, their blood pH actually rises slightly. So you can use the salt of an acid as a base, and so the endogenous acid combined with the lactate we give is removed as lactic acid, and so it actually alkalizes the blood." (said at 0:18:21)
A double-blind, crossover trial in trained cyclists found that ingesting a polylactate formulation (containing polylactate and sodium lactate) before and during prolonged cycling resulted in significantly higher blood pH and bicarbonate levels compared to a glucose polymer drink or placebo control. Ingesting lactate salts provides a conjugate base that can bind hydrogen ions or consume protons during metabolic clearance, thereby providing a mild blood-alkalizing and buffering effect during exercise. The certainty is graded low due to very small sample sizes in the available trials.
Doubly labeled water database records show that lean, healthy, free-living individuals engage in approximately one hour of daily physical activity.
"And what we found by looking at the doubly labeled water database, which was generously donated by almost every investigator whoever did a study, that people who are healthy and lean and freely living—that is eating whatever they want—they're active about an hour a day." (said at 0:20:26)
The speaker's statement accurately reflects findings derived from pooled doubly labeled water (DLW) databases. The DLW method measures total energy expenditure in free-living humans, and large pooled databases compiled from contributing global investigators (such as those analyzed for dietary reference intake equations and the IAEA DLW database consortium) demonstrate that weight-stable, healthy, normal-weight adults typically have physical activity levels (PAL) corresponding to approximately 60 minutes of moderate physical activity daily.
Thirty minutes of daily exercise improves cardiovascular function and lowers risk for heart disease, diabetes, and certain cancers, but is insufficient to manage body weight.
"Now, it's true there's good epidemiological research to indicate that if you do some activity, like 30 minutes a day, you'll improve cardiovascular function, you'll reduce your risk of heart disease and diabetes and maybe some forms of cancer, but that's not enough activity to control your body weight." (said at 0:20:58)
Substantial epidemiological and randomized trial evidence supports the speaker's claim. Public health guidelines recommending approximately 30 minutes per day of moderate-intensity physical activity (150 minutes per week) are well-established to improve cardiorespiratory fitness and significantly lower the incidence of cardiovascular disease, type 2 diabetes, and various cancers (such as colon and breast cancer). However, consensus guidelines, including the American College of Sports Medicine (ACSM) position stands, demonstrate that 150 minutes per week of physical activity without dietary restriction results in only modest weight loss. For clinically meaningful weight loss, long-term body weight maintenance, or prevention of weight regain, substantially higher volumes of physical activity (typically >250 to 300 minutes per week, or roughly 45–60 minutes per day) are generally required.
Lactate directly stimulates the production of brain-derived neurotrophic factor (BDNF).
"In terms of BDNF, which is a neurotrophic factor, it actually stimulates the growth of new brain cells. Lactate specifically has been shown to stimulate BDNF, which is quite interesting, because..." (said at 0:23:32)
Preclinical studies demonstrate that lactate, produced peripherally during exercise or administered directly, crosses the blood-brain barrier and stimulates hippocampal brain-derived neurotrophic factor (BDNF) expression. In rodent models, this induction occurs via a pathway involving SIRT1 activation, PGC-1α, and FNDC5/irisin signaling, as well as the regulation of mitochondrial quality control systems. Because the direct causal mechanism has been established in animal and in vitro models, the certainty is rated very low.
Lactate stimulates locus coeruleus neurons in the brain to release norepinephrine.
"very recently, I think it was a group in the Netherlands, they showed that lactate actually stimulates these neurons in a brain region called the locus coeruleus, which is where all the norepinephrine neurons are. So these neurons that make norepinephrine—norepinephrine is that neurotransmitter that's involved in focus and attention—and they've shown that actually specifically lactate stimulates the release of norepinephrine from those locus coeruleus neurons." (said at 0:24:35)
Preclinical experimental research confirms that lactate acts as a signaling molecule in the brain's locus coeruleus (LC) to excite noradrenergic neurons and trigger norepinephrine release. In rodent models, both astrocytic release of L-lactate and exogenous application of physiological concentrations of L-lactate depolarized LC neurons and stimulated the release of norepinephrine via a receptor-mediated, cAMP-dependent mechanism independent of its metabolic use. Because the available evidence consists of animal and cellular mechanistic studies, the certainty is graded as very low.
Lactate transporters are highly expressed throughout capillary endothelial cells, astrocytes, and neurons in the brain.
"Things get into the brain cells by transporters, and these lactate transporters are highly expressed in all the capillaries in our body, including in our astrocytes and our neurons." (said at 0:25:06)
Monocarboxylate transporters (MCTs), which mediate the transport of lactate, pyruvate, and ketone bodies, are widely expressed across the blood-brain barrier and central nervous system parenchyma. Specific isoforms carry out transport in distinct cell types: MCT1 is expressed on microvascular capillary endothelial cells and astrocytes; MCT4 is predominantly expressed by astrocytes; and MCT2 is the principal lactate transporter expressed by neurons.
Regular physical activity reduces the incidence of colon cancer and breast cancer.
"So for instance, if somebody is regularly active, why is the incidence of colon cancer reduced? Why is the incidence of breast cancer reduced?" (said at 0:22:32)
Large-scale prospective cohort studies, systematic reviews, and meta-analyses consistently demonstrate that regular physical activity is associated with a statistically significant reduction in the incidence of both colon cancer and breast cancer. In an umbrella review evaluating 22 cancer sites, colon and breast cancers had the strongest epidemiological evidence for protective associations with physical activity. A dose-response meta-analysis of prospective cohorts found that high physical activity levels were associated with a 21% reduction in colon cancer risk (relative risk 0.789) and a 14% reduction in breast cancer risk (relative risk 0.863) compared with insufficient physical activity.
- supports: Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Mill… (JAMA internal medicine 2016) · cited 1518x in the literature
"High vs low levels of leisure-time physical activity were associated with lower risks of 13 cancers: ... colon (HR, 0.84; 95% CI, 0.77-0.91), head and neck (HR, 0.85; 95% CI, 0.78-0.93), rectal (HR, 0.87; 95% CI, 0.80-0.95), bladder (HR, 0.87; 95% CI, 0.82-0.92), and breast (HR, 0.90; 95% CI, 0.87-0.93)." (abstract, results)
pubmedfull study (doi) - supports: Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart diseas… (BMJ (Clinical research ed.) 2016) · cited 1299x in the literature
"Compared with insufficiently active individuals (total activity <600 MET minutes/week), the risk reduction for those in the highly active category (≥8000 MET minutes/week) was 14% (relative risk 0.863, 95% uncertainty interval 0.829 to 0.900) for breast cancer; 21% (0.789, 0.735 to 0.850) for colon cancer" (abstract, results, passage verified)
pubmedfull study (doi) - supports: Physical activity and cancer: an umbrella review of the literature including 22 major anat… (British journal of sports medicine 2018) · cited 275x in the literature
"Physical activity was associated with lower risk of seven cancer sites (colon, breast, endometrial, lung, oesophageal, pancreas and meningioma). Only colon (a protective association with recreational physical activity) and breast cancer (a protective association with overall physical activity) were supported by strong evidence and highly suggestive evidence, respectively." (abstract, results, passage verified)
pubmedfull study (doi)
In patients with moderate to severe traumatic brain injury, elevated blood lactate levels correlate with better clinical and cognitive recovery if the blood-brain barrier is intact.
"I read a couple of papers recently on this topic of lactate in terms of patients that had moderate to severe traumatic brain injury, and they had higher levels of lactate in their bloodstream, they had a better outcome. And those patients that did not have an intact blood-brain barrier, that wasn't the same for them." (said at 0:26:37)
The claim that acute lactate metabolism and systemic availability correlate with better cognitive recovery following traumatic brain injury (TBI) is supported by clinical metabolic studies (such as research from the UCLA TBI group led by Glenn et al.). In moderate-to-severe TBI, cerebral lactate uptake and peripheral lactate mobilization serve as alternative fuels during acute post-injury glucose metabolic crises, and cerebral metabolic rate of lactate significantly predicted long-term recovery of frontal-temporal cognitive function (accounting for 22% of variance). However, the specific caveat regarding blood-brain barrier (BBB) integrity is contextually nuanced: lactate normally crosses the intact BBB via monocarboxylate transporters (MCTs) to fuel neurons and astrocytes, and severe disruption of the BBB accompanied by severe tissue ischemia can lead to pathological local lactate accumulation, which differs in clinical meaning from systemic/arterial substrate utilization.
- context: Lactate: brain fuel in human traumatic brain injury: a comparison with normal healthy cont… (Journal of neurotrauma 2015) · cited 178x in the literature
"lactate fractional extraction, an index of cerebral lactate uptake related to systemic lactate supply, approximated 11% in both healthy control subjects and TBI patients... Undiminished cerebral lactate fractional extraction and uptake suggest that arterial lactate supplementation may be used to compensate for decreased CMRgluc following TBI." (abstract, results)
pubmedfull study (doi) - supports: Acute glucose and lactate metabolism are associated with cognitive recovery following trau… (Journal of neuroscience research 2018) · cited 27x in the literature
"However, average glucose and lactate metabolism predicted recovery of frontal-temporal cognition, accounting for 23% and 22% of the variance, respectively. Also, maximum glucose metabolism, but not maximum lactate metabolism, was an inverse predictor in the recovery of frontal-temporal cognition, accounting for 23% of the variance." (abstract, results, passage verified)
pubmedfull study (doi)
Administering lactate salts can mitigate cerebral swelling and acidosis following traumatic brain injury.
"And by giving salts of lactate, we can mitigate the swelling, we can provide fuel, and we can manage the acidosis which occurs." (said at 0:18:51)
Clinical studies and randomized controlled trials in patients with severe traumatic brain injury (TBI) support the use of hypertonic sodium lactate infusions. Administration of lactate salts acts as an osmotic agent to reduce elevated intracranial pressure and brain swelling, provides an alternative aerobic energy substrate ('fuel') that spares cerebral glucose utilization, and serves as an alkalinizing buffer through hepatic conversion of lactate to bicarbonate.
- supports: Sodium lactate versus mannitol in the treatment of intracranial hypertensive episodes in s… (Intensive care medicine 2009) · cited 227x in the literature
"Acute infusion of a sodium lactate-based hyperosmolar solution is effective in treating intracranial hypertension following traumatic brain injury. This effect is significantly more pronounced than that of an equivalent osmotic load of mannitol." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Half-molar sodium lactate infusion to prevent intracranial hypertensive episodes in severe… (Intensive care medicine 2013) · cited 146x in the literature
"A 48-h infusion of SL decreased the occurrence of raised ICP episodes in patients with severe TBI, while reducing fluid and chloride balances." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Cerebral metabolic effects of exogenous lactate supplementation on the injured human brain… (Intensive care medicine 2014) · cited 196x in the literature
"Exogenous supplemental lactate can be utilized aerobically as a preferential energy substrate by the injured human brain, with sparing of cerebral glucose. Increased availability of cerebral extracellular pyruvate and glucose, coupled with a reduction of brain glutamate and ICP, suggests that hypertonic lactate therapy has beneficial cerebral metabolic and hemodynamic effects after TBI." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Role of Hypertonic Sodium Lactate in Traumatic Brain Injury Management. (Asian journal of neurosurgery 2018) · cited 12x in the literature
"Lactate, which was historically known as an end waste product, now is considered as an alternative cerebral energetic fuel. Hypertonic sodium lactate (HSL) is a promising hyperosmolar fluid which serves not only to decrease ICP but also to readily supply exogenous lactate to fulfill increased cerebral energy demand." (abstract, passage verified)
pubmedfull study (doi)
Brain-derived neurotrophic factor (BDNF) stimulates the generation and growth of new brain cells.
"In terms of BDNF, which is a neurotrophic factor, it actually stimulates the growth of new brain cells." (said at 0:23:32)
Brain-derived neurotrophic factor (BDNF) is an established neurotrophic factor that binds to tropomyosin receptor kinase B (TrkB) to promote neurogenesis, neuronal differentiation, maturation, and survival in both developing and adult mammalian brains.
- supports: Involvement of brain-derived neurotrophic factor signaling in the pathogenesis of stress-r… (Frontiers in molecular neuroscience 2023) · cited 73x in the literature
"Neurotrophins including brain-derived neurotrophic factor, BDNF, have critical roles in neuronal differentiation, cell survival, and synaptic function in the peripheral and central nervous system. It is well known that a variety of intracellular signaling stimulated by TrkB, a high-affinity receptor for BDNF, is involved in the physiological and pathological neuronal aspects via affecting cell viability, synaptic function, neurogenesis, and cognitive function." (abstract, background, passage verified)
pubmedfull study (doi) - supports: Decoding BDNF in neurodevelopmental, neurodegenerative, and neurological disorders: mechan… (Molecular biology reports 2026) · cited 2x in the literature
"Brain-Derived Neurotrophic Factor (BDNF) is an essential neurotrophin involved in neuronal survival, synaptic plasticity, and neurogenesis, critical for normal brain function as well as the pathology of neurological and psychiatric disorders." (abstract, results, passage verified)
pubmedfull study (doi)
Infusing lactate in patients with traumatic brain injury increases total cerebral carbohydrate uptake (glucose plus lactate).
"And we actually have done six patients, in collaboration with our colleagues at UCLA. We show that we can increase the carbohydrate uptake, that is the total of glucose plus lactate, in people with brain injury by infusing lactate." (said at 0:30:11)
Collaborative metabolic tracer and infusion studies conducted in human traumatic brain injury (TBI) patients by researchers at UCLA and UC Berkeley demonstrate that exogenous sodium L-lactate infusion increases net cerebral carbohydrate uptake. In these studies, infusing L-lactate changed cerebral metabolism from net lactate release to net lactate uptake (as measured by arteriovenous differences and isotopic tracers) while systemic glucose availability was maintained, resulting in increased total brain carbohydrate uptake (glucose plus lactate). The GRADE certainty is low due to the small sample sizes typical of intensive metabolic catheterization and tracer studies.
- supports: Lactate: brain fuel in human traumatic brain injury: a comparison with normal healthy cont… (Journal of neurotrauma 2015) · cited 178x in the literature
"Hence, either directly as lactate uptake, or indirectly via GNG, peripheral lactate production accounted for ~70% of carbohydrate (direct lactate uptake+uptake of glucose from lactate) consumed by the injured brain. Undiminished cerebral lactate fractional extraction and uptake suggest that arterial lactate supplementation may be used to compensate for decreased CMRgluc following TBI." (abstract, results)
pubmedfull study (doi) - supports: Lactate supplementation in severe traumatic brain injured adults by primed constant infusi… (Journal of neuroscience research 2018) · cited 24x in the literature
"Infusion of sodium L-lactate changed net cerebral lactate release, where the arteriovenous difference of lactate is negative, to net cerebral lactate uptake. Results from a mixed effects model of AVDlac with the fixed effects of infusion time, arterial lactate concentration, arterial glucose concentration and arteriovenous difference of glucose shows that doubling arterial lactate concentration (from .92 to 1.84 mM) results in an increase in AVDlac from -.078 mM to .090 mM. We did not detect changes in systemic glucose during the course of the infusion study" (abstract, results, passage verified)
pubmedfull study (doi)
D-lactate is neurotoxic.
"And D-lactate is actually neurotoxic." (said at 0:34:50)
Elevated D-lactate is well established in clinical literature and animal studies as causing neurotoxicity and metabolic encephalopathy (frequently termed D-lactate encephalopathy or D-lactic acidosis). Unlike L-lactate, excessive systemic accumulation of D-lactate crosses the blood-brain barrier and directly induces central nervous system impairment, manifesting as ataxia, confusion, delirium, and slurred speech.
- supports: D-Lactic acid-induced neurotoxicity in a calf model. (American journal of physiology. Endocrinology and metabolism 2007) · cited 52x in the literature
"Although HCl infusion produced a severe acidemia and CSF acidosis, only minor effects on neurological function were evident suggesting that d-lactate has a direct neurotoxic effect that is independent of acidosis." (abstract, results, passage verified)
pubmedfull study (doi) - supports: An extreme and life-threatening case of recurrent D-lactate encephalopathy. (Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2011) · cited 18x in the literature
"Unlike its levorotary counterpart, D-lactate has neurotoxic effects and patients suffering from a significant D-lactate burden may suffer encephalopathic symptoms." (abstract, passage verified)
pubmedfull study (doi) - supports: D-lactic acidosis: an underrecognized complication of short bowel syndrome. (Gastroenterology research and practice 2015) · cited 169x in the literature
"D-lactic acid accumulation in the blood can cause neurologic symptoms such as delirium, ataxia, and slurred speech." (abstract, passage verified)
pubmedfull study (doi)
Lactated Ringer's solution was historically prepared as a 50/50 racemic mixture of D-lactate and L-lactate.
"And so what was available was lactate, and he tried it and it seemed to work, but at that time it was a 50/50 mixture." (said at 0:35:22)
Published pharmacological and medical literature confirms that lactated Ringer's solution has historically and conventionally been prepared with racemic lactate, which is an equimolar (50/50) mixture of the D- and L-stereoisomers.
Monocarboxylate transporters transport ketones, pyruvate, and lactate.
"realize that the lactate transporters also transport ketones and pyruvate as well as lactate." (said at 0:36:22)
Monocarboxylate transporters (MCTs, notably MCT1–4 of the SLC16 family), commonly referred to as lactate transporters, mediate the proton-coupled transport of monocarboxylates across cell membranes, specifically transporting L-lactate, pyruvate, and ketone bodies (such as acetoacetate and β-hydroxybutyrate).
- supports: The monocarboxylate transporter family--Structure and functional characterization. (IUBMB life 2012) · cited 708x in the literature
"Monocarboxylate transporters (MCTs) catalyze the proton-linked transport of monocarboxylates such as L-lactate, pyruvate, and the ketone bodies across the plasma membrane." (abstract, results, passage verified)
pubmedfull study (doi) - supports: The SLC16 gene family - structure, role and regulation in health and disease. (Molecular aspects of medicine 2013) · cited 786x in the literature
"Four (SLC16A1, SLC16A3, SLC16A7, and SLC16A8) encode monocarboxylate transporters (MCT1, MCT4, MCT2, and MCT3, respectively) catalysing the proton-linked transport of monocarboxylates such as l-lactate, pyruvate and ketone bodies across the plasma membrane." (abstract, results, passage verified)
pubmedfull study (doi)
Monocarboxylate transporters are saturable, meaning all-lactate can block ketone transport and all-ketones can block lactate transport.
"The thing about it, and once you realize that they are transporters and understand how they perform, they're saturable. So if we have an all-lactate, then that'll probably block ketones, and if we have all ketones, that'll block lactate." (said at 0:36:53)
Monocarboxylate transporters (MCTs 1–4, encoded by SLC16 family genes) are carrier-mediated, proton-linked transporters that follow saturable Michaelis-Menten kinetics. They share substrate specificity across aliphatic monocarboxylates, including L-lactate, pyruvate, and the ketone bodies (acetoacetate and β-hydroxybutyrate). Because these substrates utilize the same binding and translocation mechanisms, high concentrations of one substrate (such as lactate) competitively inhibit and saturate the transporter, reducing or blocking the transport of other substrates (such as ketone bodies), and vice versa.
- supports: The SLC16 gene family - structure, role and regulation in health and disease. (Molecular aspects of medicine 2013) · cited 786x in the literature
"Four (SLC16A1, SLC16A3, SLC16A7, and SLC16A8) encode monocarboxylate transporters (MCT1, MCT4, MCT2, and MCT3, respectively) catalysing the proton-linked transport of monocarboxylates such as l-lactate, pyruvate and ketone bodies across the plasma membrane." (abstract, passage verified)
pubmedfull study (doi) - supports: Transport of lactate and other monocarboxylates across mammalian plasma membranes. (The American journal of physiology 1993) · cited 753x in the literature
"The best characterized H(+)-monocarboxylate transporter is that of the erythrocyte membrane, which transports L-lactate and a wide range of other aliphatic monocarboxylates, including pyruvate and the ketone bodies acetoacetate and beta-hydroxybutyrate." (abstract, passage verified)
pubmedfull study (doi) - supports: Substrate and inhibitor specificities of the monocarboxylate transporters of single rat he… (The American journal of physiology 1996) · cited 61x in the literature
"Of physiological interest, the ketone bodies D-beta-hydroxybutyrate and acetoacetate had K(m) values of 10 and 5.4 mM, respectively. Vmax values were similar to those of L-lactate and pyruvate and indicate that transport could limit rates of utilization of ketone bodies." (abstract, results, passage verified)
pubmedfull study (doi)
L-lactate uptake shows saturation kinetics, whereas D-lactate uptake is linear and occurs by diffusion without sharing the transporter.
"no, they don't share the transporter. So actually one of the tests we did early on, we showed a saturation kinetics with L-lactate, and D comes in in a linear fashion, so it probably comes in simply by diffusion. So fortunately, it doesn't share the transporter" (said at 0:37:55)
Transport studies in rat skeletal muscle sarcolemmal vesicles confirm that L-lactate uptake shows saturable Michaelis-Menten kinetics, whereas D-lactate uptake remains linear across a broad concentration range (1 to 200 mM) and does not substantially compete with or share the L-lactate transporter, indicating entry by simple diffusion.
The intestinal lactate transporter belongs to a different gene family than the monocarboxylate transporters in cell membranes and functions as a sodium symport rather than a proton symport.
"there was an intestinal transporter, a lactate transporter, so a different gene family than the one that's in the cell membranes. And what's neat about it is it's sodium-mediated, it's not proton—it's not a symport for protons, it's a symport for sodium." (said at 0:38:57)
The claim is accurate. Classic plasma membrane monocarboxylate transporters (MCTs 1-4) belong to the SLC16 gene family and function as proton-coupled symporters (H+-dependent). In contrast, the intestinal monocarboxylate/lactate transporters SMCT1 (SLC5A8) and SMCT2 (SLC5A12) belong to the SLC5 gene family (the solute carrier family 5, which includes sodium/glucose cotransporters) and function as sodium-coupled symporters (Na+-dependent) rather than proton symporters.
The glucose transporter in the intestinal tract is sodium-mediated, allowing glucose with salt to be absorbed faster than glucose alone.
"And also the glucose transporter in the intestinal tract is a sodium-mediated one. So, you know, how these sports drinks really work very well and work better than water regardless of the brand, because if you have glucose and a pinch of salt, it's going to get in faster than glucose alone." (said at 0:39:28)
Intestinal glucose uptake across the apical brush border membrane of enterocytes is primarily mediated by the sodium-dependent glucose cotransporter 1 (SGLT1, encoded by SLC5A1). SGLT1 operates as an electrogenic symporter, coupling the transport of two sodium ions down their electrochemical gradient to drive the transport of one glucose molecule into the enterocyte. The presence of luminal sodium is physiologically necessary for SGLT1-mediated glucose cotransport, which underlies both the rapid absorption of glucose in electrolyte-containing beverages and the therapeutic efficacy of oral rehydration solutions.
In isolated sarcolemmal vesicles, lactate outcompetes ketones, glucose, and amino acids for transporter uptake because it fits the transporter configuration better.
"The first studies we did in 1990 where we did isolated sarcolemmal vesicles... And so that's how we described the lactate transporter, is we compared it to glucose and amino acids and to ketones, and so lactate is preferred to get in, right? It outcompetes because it really fits the transporter configuration better than the other things do." (said at 0:41:41)
In a 1990 study evaluating isolated rat skeletal muscle sarcolemmal membrane vesicles, Roth and Brooks characterized the kinetics and substrate specificity of the membrane-bound monocarboxylate/lactate carrier. They demonstrated that 1 mM L(+)-lactate uptake was strongly inhibited by excess unlabeled L(+)-lactate (82%) and pyruvate (71%), but only moderately inhibited by ketone bodies (27% by beta-hydroxybutyrate, 32% by acetoacetate), and not effectively inhibited by a 10-fold excess of amino acids (alanine, aspartate, glutamate) or other non-target substrates, confirming carrier specificity and preference for lactate and pyruvate over ketones and amino acids. Because this evidence comes from in vitro animal vesicle preparations, the certainty is graded as very low.
- supports: Lactate transport is mediated by a membrane-bound carrier in rat skeletal muscle sarcolemm… (Archives of biochemistry and biophysics 1990) · cited 181x in the literature
"Furthermore, unlabeled 10 mM D(-)-lactate in the external medium could only inhibit 1 mM isotopic (L(+) uptake by 12%, whereas unlabeled 10 mM L(+)-lactate and pyruvate inhibited 82 and 71%, respectively. Additionally, 10 mM beta-hydroxybutyrate and acetoacetate could moderately inhibit (27 and 32%, respectively) 1 mM L(+)-lactate transport, but the unsubstituted aliphatic monocarboxylates (formate, acetate, propionate), tricarboxylic acid cycle intermediates (malate, succinate, oxaloacetate, alpha-ketoglutyrate, citrate), amino acids (alanine, aspartate, glutamate), and palmitate or adenosine in 10-fold excess could not effectively inhibit 1 mM L(+)lactate uptake under cis-transport conditions." (abstract, results, passage verified)
pubmedfull study (doi)
During exercise in men, infused or elevated blood lactate is metabolized preferentially over glucose by muscle, heart, and brain.
"because we've given lactate to men during exercise and it is preferred over glucose, and— In muscle, heart... Now, and also in brain." (said at 0:45:16)
Physiological tracer and infusion studies in humans demonstrate that when blood lactate concentrations are elevated (such as during exercise or via exogenous infusion), lactate is readily cleared and oxidized as a preferred fuel source relative to glucose by oxidative skeletal muscle fibers, the myocardium (heart), and the brain, down-regulating alternative substrate utilization.
Glucose metabolism and utilization in the brain are impaired following traumatic brain injury.
"But after traumatic brain injury, when the ability to use glucose is blocked, then we can supplement by giving lactate." (said at 0:45:23)
Traumatic brain injury (TBI) induces significant cerebral metabolic dysregulation, marked by disruptions in glucose processing, metabolic crisis, and impaired energy production. Research demonstrates that exogenous lactate (typically administered as hypertonic sodium lactate infusions) can serve as an alternative energy substrate for the injured brain, sparing glucose, improving neuroenergetics, reducing intracranial pressure, and supporting cerebral metabolism.
- supports: Clinical Use of Hypertonic Lactate-Current Evidence and Emerging Perspectives. (The Journal of clinical endocrinology and metabolism 2025) · cited 6x in the literature
"Infusion of hypertonic lactate has demonstrated promising effects across several clinical settings, serving as an alternative fuel for the brain that supports up to 20% of cerebral energy metabolism. In patients with traumatic brain injury, lactate treatment increases cerebral glucose availability, reduces intracranial pressure, and enhances cognitive recovery." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Metabolic Dysregulation in Traumatic Brain Injury: Mechanisms, Clinical Implications, and … (Journal of neurotrauma 2026)
"After TBI, brain energy regulation and consequential metabolic processes are disrupted. This review provides a detailed examination of metabolic alterations following TBI, including glucose and lipid processing disruptions, increased lactate levels, neurotransmitter imbalances, and oxidative stress." (abstract, passage verified)
pubmedfull study (doi)
Lactate is more reduced and contains more chemical energy than pyruvate.
"It's more reduced, so it actually has more energy than pyruvate." (said at 0:45:47)
Lactate is the reduced form of pyruvate, formed when lactate dehydrogenase catalyzes the transfer of two electrons and a proton from NADH to pyruvate (Pyruvate + NADH + H⁺ ⇌ Lactate + NAD⁺). Because lactate contains two additional electrons (reducing equivalents) compared to pyruvate's oxidized ketone group, it is in a more reduced state and has a higher chemical energy content (enthalpy of combustion). When lactate is oxidized back to pyruvate in oxidative tissues, the transferred reducing equivalent generates NADH, which yields additional ATP through the mitochondrial electron transport chain.
- supports: Lactate as a fulcrum of metabolism. (Redox biology 2020) · cited 727x in the literature
"By shuttling between producer (driver) and consumer (recipient) cells lactate fulfills at least three purposes: 1] a major energy source for mitochondrial respiration; 2] the major gluconeogenic precursor; and 3] a signaling molecule. Working by mass action, cell redox regulation, allosteric binding, and reprogramming of chromatin by lactylation of lysine residues on histones, lactate has major influences in energy substrate partitioning." (abstract, passage verified)
pubmedfull study (doi)
Neurons possess all the intact molecular apparatus necessary to take up glucose and produce lactate.
"But Rasha Hussien, who just poked her head in here, she has a paper where she showed that all the apparatus for neurons to take glucose and make lactate are intact always." (said at 0:46:18)
Preclinical biochemical and immunohistochemical studies by Hussien and Brooks demonstrated that neurons express key molecular components required for monocarboxylate transport and lactate metabolism, including monocarboxylate transporter isoforms (MCT1, MCT2) and lactate dehydrogenase (LDH) localized with neuronal mitochondria. These findings demonstrate that neurons possess the intact molecular machinery to participate in intracellular and cell-to-cell lactate transport and oxidation alongside standard glucose metabolism.
Traumatic brain injury exhibits a bimodal age distribution, occurring most frequently in young men and in older adults of both sexes.
"So there's sort of a bimodal distribution of traumatic brain injury: the young men and then people of both genders later in life." (said at 0:47:11)
Epidemiological studies of traumatic brain injury (TBI) consistently document distinct incidence peaks across the lifespan. TBI incidence is heavily skewed toward young males during adolescence and early adulthood (largely due to motor vehicle collisions, sports, and violence) and rises again sharply in older adults of both sexes (primarily resulting from falls). While some classifications describe a trimodal distribution when including early childhood (ages 0-4), the pattern across youth and older adulthood is widely recognized as bimodal.
In worm and mouse models of Parkinson's disease, lactate administration enhances mitochondrial function and increases cell viability.
"a study came out in worms and also a mice Parkinson's model—worms don't actually have a brain, but they do have Parkinson's models for worms where they have alpha-synuclein, which is one of the toxic proteins that aggregates in Parkinson's disease. They have these worms making that at an accelerated rate, but they showed that feeding the worms lactate helped improve the mitochondrial function, it increased the cell viability, and also in mice." (said at 0:48:45)
Preclinical evidence demonstrates that lactate administration can stimulate mitophagy, improve mitochondrial clearance, and protect cell viability in experimental models of Parkinson's disease, including alpha-synuclein and Pink1 mutation models, as well as ex vivo mouse brain tissue. Because these findings are derived entirely from cell cultures, invertebrate models, and animal tissue, the evidence is rated as very low certainty regarding clinical outcomes in humans.
- supports: Metabolically induced intracellular pH changes activate mitophagy, autophagy, and cell pro… (The FEBS journal 2022) · cited 44x in the literature
"Here, we used sodium pyruvate and sodium lactate to induce changes in intracellular pH in human fibroblasts with PD mutations (Pink1, Pink1/Park2, α-synuclein triplication, A53T). We have found that both lactate and pyruvate in millimolar concentrations can induce a short-time acidification of the cytosol in these cells. This induced activation of mitophagy and autophagy in control and PD fibroblasts and protected against cell death. Importantly, application of lactate to acute brain slices of WT and Pink1 KO mice also induced a reduction of pH in neurons and astrocytes that increased the level of mitophagy." (abstract, results, passage verified)
pubmedfull study (doi)
During exercise, elevated blood lactate substitutes for glucose as an energy source in the brain.
"a group from Copenhagen showed that when you exercise and your blood lactate rises, it substitutes for glucose in the brain." (said at 0:54:48)
Seminal human physiological studies led by researchers at the University of Copenhagen (such as Dalsgaard, Secher, and Quistorff) demonstrated that during high-intensity or exhaustive exercise, elevated arterial lactate is taken up by the brain in substantial quantities and oxidised as fuel rather than accumulating. Subsequent human arterio-venous catheterization studies have confirmed that as circulating lactate rises (whether through exercise or exogenous infusion), the brain shifts to preferentially oxidise lactate, resulting in a dose-dependent reduction in cerebral glucose uptake and oxidation.
Pyruvate degrades spontaneously in aqueous solution, forming toxic degradation products.
"early on it was recognized that pyruvate degrades in solution, makes toxic products. So others have tried to keep a crystalline pyruvate on hand and mix it up in saline right away and then give that at high levels." (said at 0:55:41)
The claim is supported. In aqueous solutions, pyruvate spontaneously undergoes an aldol-like condensation dimerization reaction to form 2-hydroxy-2-methyl-4-ketoglutaric acid (parapyruvate). Parapyruvate is biologically toxic because it acts as a potent inhibitor of the alpha-ketoglutarate dehydrogenase complex within the mitochondrial tricarboxylic acid (Krebs) cycle, impairing cellular respiration and inducing cellular senescence. Because of this chemical instability in solution, investigators and manufacturers have historically needed to use freshly prepared solutions or stable derivatives (such as ethyl pyruvate).
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.